CVS Health Corporation
CVS Health Corp is a U.S. health care company built around three connected businesses: retail pharmacies, pharmacy benefit management, and health care delivery/insurance. Its network includes about 9,000 retail locations, more than 1,000 walk-in and primary care clinics, and a PBM serving tens of millions of plan members. The company also sells health insurance products, including Medicare Advantage and standalone Medicare Part D plans, and uses its integrated model to steer patients across pharmacy, clinic, home, and virtual care settings. CVS Health’s core business model is to combine dispensing, benefit administration, and care delivery in one system to lower costs and improve access for consumers and payers.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueRetail pharmacy dispensing, front-store health and wellness merchandise, specialty pharmacy, and infusion services.
PBM services, specialty and mail-order pharmacy, clinical services, and care delivery assets such as clinics and home-based care.
Health insurance products and related administrative services, including Medicare Advantage and Medicare Part D.
Corporate overhead, legacy run-off products, and other non-core activities.
Customers
CVS Health sells to both institutional buyers and end consumers, which makes its customer base unusually broad for a health care company. On the B2B side, its PBM and health benefits businesses serve employers, health plans, unions, government employee groups, Medicaid and Medicare sponsors, and public/private exchange participants that buy pharmacy and medical benefit administration to control costs and manage utilization. On the B2C side, retail pharmacy customers buy prescriptions, vaccinations, and everyday health products, while patients use MinuteClinic, Oak Street Health, Signify Health, and home-based services for primary care and assessments. The company also serves covered entities and pharmaceutical manufacturers through 340B administration, rebate and pricing services, and biosimilar commercialization. Demand is driven by the need to reduce drug spend, improve access to care, and simplify navigation across pharmacy, insurance, and care delivery.
Buy PBM, formulary, network, and administrative services to manage pharmacy spend and member access.
Buy Medicare Advantage, PDP, and related health coverage products for insured access and care coordination.
Buy prescriptions, vaccinations, and front-store health products for convenience and local access.
Use MinuteClinic, Oak Street Health, Signify Health, and home-based services for primary care and assessments.
Use rebate, pricing, 340B, and biosimilar commercialization services to access distribution and administration capabilities.
Strategy
CVS Health’s strategy is to make health care simpler by connecting insurance, pharmacy, clinic, home, and virtual care in one operating system. Management is prioritizing better consumer engagement, lower costs, and improved health outcomes by using its integrated assets and enterprise data platforms. The company is also investing in digital tools, cloud capabilities, and AI to improve service delivery, automate operations, and support more personalized care. A key strategic objective is to strengthen execution in Medicare, PBM, and care delivery while using capital stewardship to support flexibility and shareholder value.
Connecting pharmacy, insurance, clinics, and home care supports lower costs and better member retention.
Medicare Advantage and PDP are large, consumer-influenced markets that can scale across the existing platform.
Digital engagement and automation are needed to compete in a consumer-driven and data-intensive health market.
Geography
CVS Health is overwhelmingly U.S.-focused, with retail stores, clinics, PBM clients, and insurance members concentrated across the United States. The company notes that medical membership is dispersed throughout the U.S., and many of its products are marketed nationwide. It also serves some medical members outside the U.S., but these activities are not described as a major revenue driver. Because the business depends on U.S. health care regulation, Medicare and Medicaid policy, and domestic drug pricing dynamics, its geographic exposure is primarily regulatory rather than international.
Risks
CVS Health faces meaningful execution risk because its model depends on accurately forecasting medical and pharmacy benefit costs, especially in insurance and PBM operations. The company is exposed to intense competition from national PBMs, health plans, retail pharmacies, urgent care providers, and new direct-to-consumer drug channels that can bypass traditional intermediaries. Regulatory and reimbursement changes in Medicare, Medicaid, 340B, and drug pricing can quickly alter margins and customer behavior because much of the business is tied to public programs and managed care. The company also carries operational risks from supply chain disruption, proprietary brand product liability, and the need to integrate large acquisitions and care-delivery assets. Goodwill impairment risk is material because the business has made major acquisitions and some reporting units have limited headroom under annual impairment testing.
- Inaccurate forecasting of health care and benefit costsImpact: HighLikelihood: High
Insurance and PBM economics depend on estimating claims, utilization, and drug spend correctly.
Exposure: Health Care Benefits and Health Services
- Competitive pressure from PBMs, health plans, and retail pharmaciesImpact: HighLikelihood: High
Customers can switch to rivals that offer lower prices, better networks, or more integrated services.
Exposure - Regulatory and reimbursement changesImpact: HighLikelihood: High
Medicare, Medicaid, 340B, and drug-pricing rules directly affect revenue and margins.
Exposure: Government programs and managed care
- Goodwill impairment on acquired businessesImpact: HighLikelihood: Low
Large acquisitions and weaker-than-expected performance can force non-cash write-downs.
Exposure: Health Care Delivery and other acquired reporting units
- Supply chain and proprietary brand product riskImpact: MediumLikelihood: Low
Retail and private-label products depend on stable sourcing, quality control, and intellectual property protection.
Exposure: Pharmacy & Consumer Wellness
Accounting
Judgemental itemsClaims and utilization estimates drive reported profitability in the insurance business.
Impact: Can cause material swings in operating results if assumptions prove wrong
The timing and netting of manufacturer rebates and service fees affect reported revenue and margin.
Impact: Affects segment revenue mix and comparability across periods
Large acquired reporting units must be tested annually and when indicators arise.
Impact: Can create large non-cash charges and signal weaker acquisition performance
Acquired customer relationships and other intangibles reduce operating income over time.
Impact: Depresses reported earnings relative to cash generation
Similar listed companies
Publicly listed companies with a comparable business focus.
Cardinal Health, Inc
CAH · Wholesale-Drugs, Proprietaries & Druggists' Sundries
CV Sciences, Inc.
CVSI · Pharmaceutical Preparations
Community Health Systems, Inc
CYH · Services-General Medical & Surgical Hospitals, NEC
Definitive Healthcare Corp.
DH · Services-Prepackaged Software
P3 Health Partners Inc.
PIII · Services-Health Services
Kenvue Inc.
KVUE · Perfumes, Cosmetics & Other Toilet Preparations
Last updated: 24/09/2026